ARCHIVES

Two Second-Line CML Drugs Work Front-Line, Studies Find

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Kirsten Goldberg Leaves The Cancer Letter For ASCO

January 7, 2011

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

Chronobiology Review Still Delayed

May 5, 1989

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991